Trial intelligence / Profile preview

Endotoxin and Alcohol Consumption in AUD

NCT04527185Phase 2Completed

Sponsor
Yale University
Start
Feb 2022
Primary completion
Oct 2024
Modality
Biologic
Countries
1
01

Overview

A Phase 2 trial of lipopolysaccharide endotoxin in alcohol use disorder (AUD), sponsored by Yale University. Started Feb 2022; status: completed.

02

Drugs

lipopolysaccharide endotoxin
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT04527185.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04527185.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call